Rate-Control Treatment and Mortality in Atrial Fibrillation - Chao, Tze-Fan; Liu, Chia-Jen; Tuan, Ta-Chuan; Chen, Su-Jung; Wang, Kang-Ling; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chen, Tzeng-Ji; Chiang, Chern-En; Chen, Shih-Ann (Circulation (New York, N.Y.), 2015)
Keywords: Adrenergic beta-Antagonists - therapeutic use; Aged; Aged, 80 and over; Anti-Arrhythmia Agents - therapeutic use; Anticoagulants - therapeutic use; Atrial Fibrillation - drug therapy; Atrial Fibrillation - mortality; Atrial Fibrillation - physiopathology; Calcium Channel Blockers - therapeutic use; Cause of Death; Cohort Studies; Comorbidity; Confounding Factors (Epidemiology); Digoxin - therapeutic use; Drug Utilization; Female; Heart Rate - drug effects; Humans; Income; Male; Middle Aged; Practice Guidelines as Topic; Proportional Hazards Models; Residence Characteristics; Risk Reduction Behavior; Taiwan - epidemiology; Taiwan; adrenergic beta antagonists; atrial fibrillation; heart rate; digoxin; calcium channel blockers